ABSTRACT

profileStallion90

Use one of the below samples to complete this assignment. Please use the attached document for information in creating this abstract. 

 

Sample 1:

VA Physician Shortages and Increased Wait times

Objective: To shed light on the soaring drug prices and its negative effect on individual health and Healthcare spending.

The cost of prescription drugs has been an ongoing issue and topic of discussion in Healthcare for many years. In recent years the issue of drug prices has risen in public opinion and policymaker’s agenda. Naloxone is an antidote for narcotic overdose and in the last 2 years its price increased 17 fold, Doxycycline hyclate (100mg) soared from $20 for 500 capsules in October 2013 to $1849 in April 2014, Pravastatin 10mg rose to $196 from $27 for one-year supply. It is concerning that many of these are generic medications. Harvoni developed by Gilead Sciences for treatment of Hepatitis C costs $94,500 for 12 weeks.

In 2015, Turing Pharmaceuticals bought Daraprim used to treat toxoplasmosis in immunocompromised patients and increased the price 5000%. This led to public outrage, and other examples of price gouging led the Congress to question drug company activities. California will vote on its Drug Price Relief Act Initiative, which if it passes would allow state health agencies to negotiate directly with drug companies, tying it to the price paid by the US Department of Veteran Affairs. The VA is reported to pay about 42% of drug market price while MediCal pays about 51%. Rising drug prices is high in public opinion and many politicians have weighed in including presidential candidates. US drug spending in 2013 was $330 billion, and specialty drugs alone are expected to cost $400 billion by 2020.

California Drug Price Relief Act if it gets a “yes” could set precedence for the rest of the country. This hopefully will usher in some level of price control for Big Pharma, and make life-saving drugs available for all.

Sample 2:

Drug price wars!

Top of Form

Objective: To shed light on the soaring drug prices and its negative effect on individual health and Healthcare spending.

The cost of prescription drugs has been an ongoing issue and topic of discussion in Healthcare for many years. In recent years the issue of drug prices has risen in public opinion and policymaker’s agenda. Naloxone is an antidote for narcotic overdose and in the last 2 years its price increased 17 fold, Doxycycline hyclate (100mg) soared from $20 for 500 capsules in October 2013 to $1849 in April 2014, Pravastatin 10mg rose to $196 from $27 for one-year supply. It is concerning that many of these are generic medications. Harvoni developed by Gilead Sciences for treatment of Hepatitis C costs $94,500 for 12 weeks.

In 2015, Turing Pharmaceuticals bought Daraprim used to treat toxoplasmosis in immunocompromised patients and increased the price 5000%. This led to public outrage, and other examples of price gouging led the Congress to question drug company activities. California will vote on its Drug Price Relief Act Initiative, which if it passes would allow state health agencies to negotiate directly with drug companies, tying it to the price paid by the US Department of Veteran Affairs. The VA is reported to pay about 42% of drug market price while MediCal pays about 51%. Rising drug prices is high in public opinion and many politicians have weighed in including presidential candidates. US drug spending in 2013 was $330 billion, and specialty drugs alone are expected to cost $400 billion by 2020.

California Drug Price Relief Act if it gets a “yes” could set precedence for the rest of the country. This hopefully will usher in some level of price control for Big Pharma, and make life-saving drugs available for all.

 

Sample 3

Home Based Care

Objective: To improve CMSs’ Medicare reimbursement incentives for at home chronic care management services performed by healthcare providers.


3 million baby boomers will hit retirement age every year for the next 20 years, 60% of boomers are expected to have multiple chronic conditions straining healthcare resources. The elderly population with chronic medical conditions account for approximately half of Medicare expenditures plundering the cost of care. However, there is a solution, Medicare in 2012 launched the Independence at Home Demonstration, to 14 practices, to elicit improvement of care for Medicare beneficiaries with multiple chronic conditions by providing services to improve quality of care and quality of life while lowering healthcare costs. Preliminary results showed the Affordable Care Act payment model saved more than $25 million in the first performance year proving the Independence at Home practice succeeded in fewer hospital readmissions and fewer hospital visits for diabetes, high blood pressure, asthma and pneumonia. CMS passed $11.7 million of the savings to the providers.

Home visits are part of a thriving data analysis industry that impacts value based care for sustaining patient quality and cost effectiveness. Funding for house-call programs come from a combination of Medicare fee-for-service programs, grants and private insurances. The Independence at Home has been presented to the Senate Finance Committee’s Chronic Care Working Group to the goal of making it available nationwide.

 

Home Healthcare is high on the public agenda and will be advocated by the baby boomer generation. The window of opportunity is still opening as further innovations in telehealth are on the horizon to help facilitate and cultivate home care. With further media coverage and community initiatives to implement population health and preventative medicine, healthcare providers as well as their patients will further precipitate public attention and evoke changes to healthcare policies.

Bottom of Form

 

 

  • 8 years ago
  • 15
Answer(1)

Purchase the answer to view it

blurred-text
NOT RATED
  • attachment
    mhac_1.docx